Rogaine was originally developed as a blood pressure medication. The active ingredient, minoxidil, was created to treat severe hypertension and was sold in pill form under the brand name Loniten, which the FDA approved in 1979. It wasn’t until patients started growing unexpected hair that researchers pivoted toward what would become Rogaine’s famous second life.
How a Blood Pressure Drug Was Born
The story begins in 1960, when chemists at the Upjohn Company started investigating a compound they had ordered from a chemical catalogue for its effects on gastric acid. That line of research didn’t pan out as expected, but the team kept synthesizing related compounds, eventually producing minoxidil. When they tested it, the results were striking: dramatic blood pressure reductions in patients with severe, drug-resistant hypertension.
Minoxidil works by opening potassium channels in the walls of blood vessels. This relaxes the smooth muscle surrounding those vessels, causing them to widen and blood pressure to drop. The drug is actually a prodrug, meaning the body has to convert it into an active form (a sulfate compound) before it does anything. That conversion happens in the liver, which is why the original version was an oral pill. In the era before many of today’s common blood pressure medications existed, minoxidil filled a real need for patients whose hypertension didn’t respond to anything else.
The Unexpected Side Effect
During clinical trials in the 1970s, researchers noticed something they hadn’t planned for: patients taking minoxidil for their blood pressure were growing more hair. Not just on their scalps, but across their bodies. This excessive hair growth, called hypertrichosis, was consistent enough across patients that it caught the attention of both doctors and the pharmaceutical company.
At the time, no FDA-approved treatment for hair loss existed. Upjohn recognized the commercial potential and began investigating whether minoxidil could be reformulated as a topical treatment applied directly to the scalp. The challenge was significant. They needed to deliver enough of the drug through the skin to stimulate hair follicles without sending meaningful amounts into the bloodstream, where it would lower blood pressure in people who didn’t need it lowered.
From Pill to Scalp Solution
On August 18, 1988, the FDA approved topical minoxidil under the brand name Rogaine, making it the first product ever cleared by U.S. regulators for the treatment of hair loss. That approval came nearly a decade after the oral version had been approved for hypertension, reflecting the years of work needed to develop and test the topical formulation.
The dosages tell the story of just how different the two uses are. For blood pressure, the standard oral dose ranges from 10 to 40 milligrams daily. For hair loss, when doctors prescribe the oral form off-label today, they typically start patients at just 0.625 to 1.25 milligrams, a fraction of the hypertension dose. Australian dermatologist Rod Sinclair pioneered this ultra-low-dose approach, and clinics like the Cleveland Clinic now use it routinely, having patients split 2.5 mg pills into quarters. The topical version sidesteps the dosage question entirely by delivering the drug locally rather than systemically.
Is Minoxidil Still Used for Blood Pressure?
Oral minoxidil never disappeared from the blood pressure world, but its role shrank considerably. When it was first developed, doctors didn’t yet have calcium channel blockers, ACE inhibitors, or ARBs, the medications that now form the backbone of hypertension treatment. Once those drugs arrived, minoxidil was pushed to the margins. A 2024 paper in the American Heart Association’s journal Hypertension described it as “largely overlooked in contemporary clinical practice.”
That said, it still has a niche. For patients with resistant hypertension, the kind that doesn’t respond adequately to three or more medications, minoxidil remains a useful option. Some clinicians have found it works well as a substitute for calcium channel blockers in these difficult cases. It’s not a first-line drug anymore, but for the same reason it was originally developed, treating the hardest-to-control blood pressure, it still has a place in medicine’s toolkit.
Why It Works on Hair Follicles
The same potassium channel mechanism that relaxes blood vessels also affects hair follicles, though researchers still don’t fully understand every step of the process. Minoxidil needs to be converted into its active sulfate form to work, and this conversion can happen in hair follicles themselves, not just the liver. Once activated, it appears to increase blood flow to follicles, extend the growth phase of the hair cycle, and stimulate follicles that have begun to miniaturize (the process that makes hair progressively thinner in pattern baldness).
This is why some people respond to minoxidil better than others. Individual differences in the enzyme that converts minoxidil to its active form may explain why the drug works well for some and barely at all for others. It’s the same drug doing the same basic thing, opening potassium channels, but in a completely different tissue than its inventors ever intended.